Research history

1940s–1950s

Purine Analogues: What a Rescue Test Shows

Read Gertrude Elion’s account of early purine analogue screening and work through an original example separating growth inhibition from pathway evidence.

Original reading diagram comparing growth inhibition, nutrient rescue and follow-up.

The short answer

If a nutrient restores growth inhibited by a related compound, the reversal narrows the next question. The assay still leaves work to do.

Evidence at a glance

What can restored growth establish about an inhibitor?

Read each observation alongside the particular inference it supports.

Historical source claims and original reasoning exercises are distinguished in the text.
Record or exampleObservationInterpretation
InhibitionGrowth falls in a culture exposed to a candidate.Establishes an effect in the screen.
RescueA selected nutrient restores some growth in the model.Supports a pathway question to investigate.
Follow-upA different method tests the proposed step.Needed to distinguish mechanisms.

The historical screening clue

Elion recalls a study in which 2,6-diaminopurine inhibited growth of Lactobacillus casei. Adenine could reverse that inhibition under the conditions she discusses. The pattern suggested a possible connection between how the compounds were processed. The group followed it by examining resistant bacteria and by studying how candidates acted in other systems.

Sources for this section: [1]

Build a three-row control

In an invented table, assign a culture with neither compound a growth score of 100. With inhibitor alone, set the score at 25. With inhibitor and nutrient A, set it at 85. The third score shows a partial rescue. Add a fourth culture with A alone: if A greatly raises growth even without inhibitor, a general growth benefit becomes a competing interpretation. All four rows help explain why reversal is a comparison, rather than a direct view of a reaction.

What the model leaves open

Try a second nutrient, B, with inhibitor present. If B fails to restore growth in the classroom table, the result supports a more specific association with A. It still leaves several ways for A to matter. It could change entry into the cell, supply a needed metabolite or compete at a processing step. Distinguishing those explanations calls for measurements other than growth alone.

Follow the compound across records

Elion’s lecture describes candidate activity and adverse effects in other settings. A screen asks which substances are worth investigating. Questions about what happens in a body and whether an intervention is useful require additional evidence. Comparing the lecture to Hitchings’s different enzyme focus also helps readers keep the research program wider than any one compound or assay.

Sources for this section: [1] · [2]

Continue the chronology

Biography context

Explore United States through connected lives

Connected biographies

The researcher behind the records

Gertrude Elion seated in a light jacket.
United StatesCulture

1918–1999

Gertrude Elion

Medicinal chemistElion investigated compounds that interfere with nucleotide metabolism.Read biography

Quick answers

Common questions

Does a rescue identify one enzyme by itself?
The assay narrows hypotheses; identifying a particular enzyme requires additional evidence.

Primary and institutional sources

How this history was checked

The notes distinguish period evidence, later interpretation, and original exercises. This article was reviewed on 5 November 2026.

  1. Gertrude B. Elion, Nobel lecture, 1988The Purine Path to Chemotherapy
  2. George H. Hitchings, Nobel FoundationGeorge H. Hitchings: Nobel lecture